International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Pages 3-9 , April 2010

Clinical assessment of insulin action during late pregnancy in women at risk for gestational diabetes: Association of maternal glycemia with perinatal outcome

  • Karen E. Elkind-Hirsch

      Affiliations

    • Woman’s Health Research Department, Woman’s Hospital, Baton Rouge, LA, United States
    • Corresponding Author InformationCorresponding author. Address: Woman’s Health Research Department, Woman’s Hospital, 9050 Airline Highway, Baton Rouge, LA 70815, United States. Tel.: +1 225 231 5278; fax: +1 225 924 8225.
    • ,
  • Beverly W. Ogden

      Affiliations

    • Woman’s Pathology Laboratory, Woman’s Hospital, Baton Rouge, LA, United States
    • ,
  • Carmen J. Darensbourg

      Affiliations

    • Woman’s Health Research Department, Woman’s Hospital, Baton Rouge, LA, United States
    • ,
  • Brett L. Schelin

      Affiliations

    • Woman’s Pathology Laboratory, Woman’s Hospital, Baton Rouge, LA, United States

Received 1 September 2009 ,Accepted 16 December 2009.

References 

  1. Stanley K, Fraser R, Bruce C. Physiological changes in insulin resistance in human pregnancy: longitudinal study with the hyperinsulinaemic euglycaemic clamp technique. Br J Obstet Gynaecol. 1998;105:756–759
  2. Catalano PM, Tyzbir ED, Wolfe RR, Calles J, Roman NM, Amini SB, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol. 1993;264:E60–E67
  3. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol. 1999;180:903–916
  4. Kirwan JP, Huston-Presley H, Kalhan SC, Catalano PM. Clinically useful estimates of insulin sensitivity during pregnancy. Diabetes Care. 2001;24:1602–1607
  5. Ryan EA, O’Sullivan MJ, Skyler JS. Insulin action during pregnancy. Studies with the euglycemic clamp technique. Diabetes. 1985;34:380–389
  6. Homko C, Sivan E, Chen X, Reece EA, Boden G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab. 2001;86:568–573
  7. Xiang AH, Peters RK, Trigo E, Kjos SL, Lee WP, Buchanan TA. Multiple metabolic defects during late pregnancy in women at high risk for diabetes. Diabetes. 1999;48:848–854
  8. Buchanan TA. Pancreatic β-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab. 2001;86:989–993
  9. Boyd ME, Usher RH, McLean FH. Fetal macrosomia: prediction, risks, proposed management. Obstet Gynecol. 1983;61(6):715–722
  10. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. For HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002
  11. Schafer-Graf UM, Dupak J, Vogel M, Dudenhausen JW, Kjos SL, Buchanan TA. Hyperinsulinism, neonatal obesity and placental immaturity in infants born to women with one abnormal glucose tolerance test value. J Perinat Med. 1998;26:27–36
  12. Sermer M, Naylor CD, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternal–fetal outcomes in 3637 women without gestational diabetes: the Toronto Tri-Hospital gestational diabetes project. Am J Obstet Gynecol. 1995;173:146–156
  13. Jensen DM, Damm P, Sorensen B, Molsted-Pedersen L, Westergaard JG, Klebe J. Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol. 2001;185:413–419
  14. Leikin EL, Jenkins JH, Pomerantz GA, Klein L. Abnormal glucose screening tests in pregnancy: a risk factor for fetal macrosomia. Obstet Gynecol. 1987;69:570–573
  15. Mello G, Parretti E, Mecacci F, et al. Risk factors for fetal macrosomia: the importance of a positive oral glucose challenge test. Eur J Endocrinol. 1997;137:27–33
  16. Tallarigo L, Giampietro O, Penno G, Miccoli R, Gregori G, Navalesi R. Relation of glucose tolerance to complications of pregnancy in nondiabetic women. N Engl J Med. 1986;315:989–992
  17. Solomon CG, Willet WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA. 1997;278:1078–1083
  18. Haffner SM, D’Agostino R, Saad MF, Bergman RN, Savage PJ, Rewers M, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. Diabetes. 1996;45:742–748
  19. Saldana TM, Siega-Riz AM, Adair L, Savitz DA, Thorp JM. The association between impaired glucose tolerance and birth weight among black and white women in central North Carolina. Diabetes Care. 2003;26:656–661
  20. Steinfeld JD, Valentine S, Lerer T, Ingardia CJ, Wax JR, Curry SL. Obesity-related complications of pregnancy varies by race. J Matern Fetal Med. 2000;9:238–241
  21. Scholl TO, Chen X, Gaughan C, Smith WK. Influence of maternal glucose level on ethnic differences in birth weight and pregnancy outcome. Am J Epidemiol. 2002;156:498–506
  22. Kjos S, Buchanan T, Greenspoon J, Montoro M, Bernstein G, Mestman J. Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months postpartum. Am J Obstet Gynecol. 1990;163:93–98
  23. National Diabetes Data Group . Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–1057
  24. Elkind-Hirsch K, Darensbourg C, Ogden B, Ogden L, Hindelang P. Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive. Contraception. 2007;76:348–356
  25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  26. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care. 1999;22:1462–1470
  27. Sluiter WJ, Erkelens DW, Terpstra P, Reitsma WD, Doorendos H. Glucose intolerance and insulin release, a mathematical approach, I: assay of the beta cell response after glucose loading. Diabetes. 1976;25:241–244
  28. Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, et al. The Diabetes Prevention Program Research Group: role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program. Diabetes. 2005;54:2404–2414
  29. Kahn SE. The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 2003;46:3–19
  30. Ergin T, Lembet A, Duran H, Kuscu E, Bagis T, Saygili E, et al. Does insulin secretion in patients with one abnormal glucose tolerance test value mimic gestational diabetes mellitus?. Am J Obstet Gynecol. 2002;186:204–209
  31. Wareham NJ, Phillips DI, Byrne CD, Hales CN. The 30 min insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabetes Med. 1995;12:931
  32. Retnakaran R, Hanley AJ, Raif N, Hirning CR, Connely PW, Sermer M, et al. Adiponectin and β-cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia. 2005;48:993–1001
  33. Kauffman RP, Castracane VD, Peghee P, Baker TE, Van Hook JW. Detection of gestational diabetes mellitus by homeostatic indices of insulin sensitivity: a preliminary study. Am J Obstet Gynecol. 2006;194:1576–1582
  34. Osei K, Cottrell DA, Harris B. Differences in basal and poststimulation glucose homeostasis in nondiabetic first-degree relatives of black and white patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 1992;75:82–86
  35. Preeyasombat C, Bacchetti P, Lazar AA, Lustig RH. Racial and etiopathologic dichotomies in insulin hypersecretion and resistance in obese children. J Pediatr. 2005;146:474–481
  36. Hillier TA, Pedula KL, Vesco KK, Schmidt MM, Mullen JA, LeBlanc ES, et al. Excess gestational weight gain: modifying fetal macrosomia risk associated with maternal glucose. Obstet Gynecol. 2008;112(5):1007–1014
  37. Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B. Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care. 2008;31:2026–2031
  38. Lapolla A, Dalfrà MG, Bonomo M, Castiglioni MT, Di Cianni G, Masin M, et al. Can plasma glucose and HbA1c predict fetal growth in mothers with different glucose tolerance levels?. Diabetes Res Clin Pract. 2007;77:465–470
  39. Yogev Y, Langer O, Xenakis EM, Rosenn B. The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic women. J Matern Fetal Neonatal Med. 2005;17:29–34

PII: S1877-5934(09)00063-0

doi: 10.1016/j.ijdm.2009.12.006

International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Pages 3-9 , April 2010

Article Tools

* Image Usage & Resolution